French device company Biocorp has announced the launch of its Inspair sensor, which it says is “capable of converting any pressurized metered dose inhaler into a connected device.”
According to the company, the sensor works with adaptors specially designed to fit the mouthpieces of most commonly marketed MDIs for asthma and/or COPD, and it records data on the number of inhalations, inhaler position, and coordination of actuation with inhalation. The sensor also provides feedback to the patient.
Biocorp Founder and CEO Jacques Gardette commented, “Biocorp’s objective is to develop innovative solutions in order to improve treatment compliance by patients suffering from chronic diseases. Significant applications have been developed in diabetology, endocrinology and neurology with the Datapen and Easylog devices, and our new sensor Inspair also positions us in the area of chronic lung diseases which affect an increasing number of people in need of new solutions to improve compliance.”
Read the Biocorp press release.
